Secondary navigation
Accents
12 lawyers
153 clients
Overview
- Advising TEVA Pharmaceutical Industries Ltd. on various regulatory and intellectual property matters and successful representing the client before the Bulgarian Patent Office (BPO) in patent invalidation administrative proceedings.
- Advising Swedish Orphan Biovitrium AB in relation to all aspects of its operations in Bulgaria, including patient support service agreements, localisation of HCC agreements, corporate matters and regulatory compliance, distribution and advertisement. Recently we assisted with the preparation of a local compliance presentation for a Bulgarian contract partners of the client.
- Advised Pharmascience on Bulgarian pharmaceutical regulatory aspects of reimbursement of medicinal products.
- Assisting Aspen Pharma Europe GmbH on general corporate and regulatory matters, privacy issues, contracts review, de-listing of products.
- Advised Abbott on the Bulgarian legal aspects of the global sale of Abbott Laboratories branded specialty and generics business (Abbott Generics) to the Generic Drugmaker Mylan Inc.
- Advised Pierre Fabre Dermo-Cosmetique Bulgaria on trademark opposition and domain cancellation proceedings.
- Advised PRINTIVO GROUP AD on R&D collaboration agreement with Swiss partner Scailyte AG, related to cultivation and analysis of bioprinted cells; preparing employment contracts, assisted and consulted with employment matters and recruitment.
- Provided review and localisation of the sub-distributor agreement that Medison Pharma Trading AG intended to conclude with its sub-distributor in Bulgaria.
- Advising Sandoz and representing it before the Bulgarian competition authority with regard to acquisition of the cephalosporins business of GlaxoSmithKline and obtaining of a merger clearance decision.
- Advising AbbVie, Inc., Abbott Laboratories SA and Mylan, Inc. on pharma regulatory matters, pricing, reimbursement, marketing and promotion, various regulatory, employment and corporate matters, structuring of patient support programs, clinical trial arrangements.
- Representing Pierre Fabre Medicament in three opposition proceedings before the Bulgarian Patent Office against applications for registration of brands.
- Acquisition of the Cephalosporin business of GlaxoSmithKline by Sandoz/Novartis and on corporate matters and contractual relationships.
- Advised Bayer AG on the merger notifications in relation to foreign to foreign transactions.
- Advised Research Pharmaceutical Services Inc. on the application of a labour leasing scheme in light of the national employment legislation.
- Advised Acibadem City Clinic Tokuda Hospital EAD on the merger of Acibadem City Clinic Burgas ЕOOD and the merger of Acibadem City Clinic Healthcare Center Burgas ЕOOD into Acibadem City Clinic Diagnostic and Consultation Center Tokuda EAD. The work included legal advice on the minority shareholders buy-out and termination of the employment contracts of the merging companies.
- Advising Blocks Health and Social Care on the acquisition, financing and the greenfield development of a rehabilitation, long-term care center and hospice for the elderly in Sofia, Bulgaria.
- Advised City Clinic Group and its shareholders on the acquisition of Bulgaria-based Tokuda Hospital and its subsidiaries and a simultaneous merger with City Clinic, another leading healthcare operator in Bulgaria.
- Advised Acibadem City Clinic EAD (the largest group of medical facilities in Bulgaria and a part of part of the international organization IHH Healthcare Berhad) on the structuring, due diligence and acquisition of an operating oncology hospital building.
- Advises a world pharma company on comprehensive day-to-day legal matters, including mainly regulatory matters, relationship with the Health Insurance Fund, employment, corporate, commercial, tax, data protection and privacy matters, as well as on anti-corruption and litigation matters.